Mitsubishi UFJ Asset Management
SGMO

Mitsubishi UFJ Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-135,382
Closed -$88.8K – 1643
2025
Q1 		$88.8K Buy
135,382
+11,345
+9% +$12K ﹤0.01% 1033
2024
Q4 		$161K Buy
+124,037
New +$227K ﹤0.01% 1022
2023
Q2 		– Sell
-76,068
Closed -$134K – 1143
2023
Q1 		$134K Buy
76,068
+6,458
+9% +$18.4K ﹤0.01% 1070
2022
Q4 		$219K Buy
69,610
+7,906
+13% +$30.7K ﹤0.01% 1012
2022
Q3 		$302K Sell
61,704
-1,170
-2% -$6.01K ﹤0.01% 976
2022
Q2 		$260K Buy
62,874
+29,131
+86% +$126K ﹤0.01% 1013
2022
Q1 		$196K Buy
33,743
+2,882
+9% +$17.1K ﹤0.01% 1061
2021
Q4 		$241K Buy
30,861
+1,980
+7% +$17.2K ﹤0.01% 1053
2021
Q3 		$260K Buy
28,881
+780
+3% +$7.71K ﹤0.01% 1026
2021
Q2 		$336K Sell
28,101
-6,285
-18% -$71.2K ﹤0.01% 1021
2021
Q1 		$431K Buy
34,386
+11,424
+50% +$154K ﹤0.01% 907
2020
Q4 		$358K Buy
22,962
+6,099
+36% +$71.4K ﹤0.01% 869
2020
Q3 		$159K Sell
16,863
-826
-5% -$8.93K ﹤0.01% 921
2020
Q2 		$158K Sell
17,689
-427
-2% -$3.96K ﹤0.01% 917
2020
Q1 		$115K Buy
18,116
+3,437
+23% +$25.5K ﹤0.01% 917
2019
Q4 		$121K Buy
14,679
+202
+1% +$1.86K ﹤0.01% 938
2019
Q3 		$131K Buy
14,477
+2,515
+21% +$28.2K ﹤0.01% 875
2019
Q2 		$129K Sell
11,962
-2,770
-19% -$29.5K ﹤0.01% 892
2019
Q1 		$141K Buy
14,732
+768
+5% +$7.84K ﹤0.01% 841
2018
Q4 		$154K Buy
13,964
+4,599
+49% +$57.1K ﹤0.01% 782
2018
Q3 		$159K Buy
+9,365
New +$142K ﹤0.01% 796

Other funds holding SGMO

YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Mitsubishi UFJ Asset Management's SGMO Position: Q2 2025 in Review

Mitsubishi UFJ Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2025, closing a stake of 135,382 shares — an estimated $88.8K sold.

Mitsubishi UFJ Asset Management first reported a position in SGMO in Q3 2018 and held it in 21 quarters. The position peaked at $431K in Q1 2021. 114 funds tracked by Wall St. Rank hold SGMO as of Q2 2025.

  • Mitsubishi UFJ Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2025 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 135,382 SANGAMO THERAPEUTICS INC shares in Q2 2025, an estimated $88.8K.
  • Mitsubishi UFJ Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q3 2018 and held it in 21 quarters.
  • Mitsubishi UFJ Asset Management's SANGAMO THERAPEUTICS INC position peaked at $431K in Q1 2021.
  • 114 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2025.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.